Mylan Institutional, Inc. (d.b.a. UDL Laboratories) recalls Meclizine Hydrochloride Tablets, USP, 25 mg Tablets, Packaged in 10 x 10 Tablet Blister Pack Packages, Rx Only. Manufac…
- Recall date
- November 2, 2015
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0235-2016
- FDA classification
- Class III
- Brand / firm
- Mylan Institutional, Inc. (d.b.a. UDL Laboratories)
- Sold / distributed
- US Nationwide including Puerto Rico
Why it was recalled
Failed Impurities/Degradation Specifications: Out of specification for impurities.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Meclizine Hydrochloride Tablets, USP, 25 mg Tablets, Packaged in 10 x 10 Tablet Blister Pack Packages, Rx Only. Manufactured by: Par Pharmaceutical Companies, Inc., Spring Valley, NY 10977. Mylan. NDC: 51079-090-20.
Get recall alerts
Free email alert whenever Mylan Institutional, Inc. (d.b.a. UDL Laboratories) has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Mylan Institutional, Inc. (d.b.a. UDL Laboratories)